These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 37076274)

  • 21. Diagnostic accuracy of controlled attenuation parameter measured by transient elastography for the non-invasive assessment of liver steatosis: a prospective study.
    Lupșor-Platon M; Feier D; Stefănescu H; Tamas A; Botan E; Sparchez Z; Maniu A; Badea R
    J Gastrointestin Liver Dis; 2015 Mar; 24(1):35-42. PubMed ID: 25822432
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ultrasound and FibroScan
    Salmi A; di Filippo L; Ferrari C; Frara S; Giustina A
    Endocrine; 2022 Nov; 78(2):262-269. PubMed ID: 35980569
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic performance of ultrasound attenuation imaging for assessing low-grade hepatic steatosis.
    Jang JK; Kim SY; Yoo IW; Cho YB; Kang HJ; Lee DH
    Eur Radiol; 2022 Mar; 32(3):2070-2077. PubMed ID: 34549325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of point shear wave elastography and transient elastography in the evaluation of patients with NAFLD.
    Argalia G; Ventura C; Tosi N; Campioni D; Tagliati C; Tufillaro M; Cucco M; Svegliati Baroni G; Giovagnoni A
    Radiol Med; 2022 May; 127(5):571-576. PubMed ID: 35290569
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnosis of steatohepatitis and fibrosis in biopsy-proven nonalcoholic fatty liver diseases: including two-dimension real-time shear wave elastography and noninvasive fibrotic biomarker scores.
    Zhou J; Yan F; Xu J; Lu Q; Zhu X; Gao B; Zhang H; Yang R; Luo Y
    Quant Imaging Med Surg; 2022 Mar; 12(3):1800-1814. PubMed ID: 35284290
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Factors Associated with Disagreement of Fibrosis Stages between 2D-Shear Wave Elastography and Transient Elastography in Chronic Hepatitis B.
    Miodownik FG; Cardoso AC; Cancella Nabuco L; Franz C; Perez R; Alves Villela-Nogueira C
    Viruses; 2023 Mar; 15(4):. PubMed ID: 37112826
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic accuracy of two-dimensional shear wave elastography and transient elastography in nonalcoholic fatty liver disease.
    Sharpton SR; Tamaki N; Bettencourt R; Madamba E; Jung J; Liu A; Behling C; Valasek MA; Loomba R
    Therap Adv Gastroenterol; 2021; 14():17562848211050436. PubMed ID: 34646360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Controlled attenuation parameter for the assessment of liver steatosis in comparison with liver histology: a single-centre real life experience.
    Baumeler S; Jochum W; Neuweiler J; Bergamin I; Semela D
    Swiss Med Wkly; 2019 Apr; 149():w20077. PubMed ID: 31026041
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for the Diagnosis of Liver Steatosis and Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
    Zenovia S; Stanciu C; Sfarti C; Singeap AM; Cojocariu C; Girleanu I; Dimache M; Chiriac S; Muzica CM; Nastasa R; Huiban L; Cuciureanu T; Trifan A
    Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33925569
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prospective Comparison of Attenuation Imaging and Controlled Attenuation Parameter for Liver Steatosis Diagnosis in Patients With Nonalcoholic Fatty Liver Disease and Type 2 Diabetes.
    Dioguardi Burgio M; Castera L; Oufighou M; Rautou PE; Paradis V; Bedossa P; Sartoris R; Ronot M; Bodard S; Garteiser P; Van Beers B; Valla D; Vilgrain V; Correas JM;
    Clin Gastroenterol Hepatol; 2024 May; 22(5):1005-1013.e27. PubMed ID: 38072287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlled attenuation parameter (CAP) for detection of hepatic steatosis in patients with chronic liver diseases: a prospective study of a native Korean population.
    Chon YE; Jung KS; Kim SU; Park JY; Park YN; Kim DY; Ahn SH; Chon CY; Lee HW; Park Y; Han KH
    Liver Int; 2014 Jan; 34(1):102-9. PubMed ID: 24028214
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Prevalence of Liver Steatosis and Fibrosis Assessed by Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter in Apparently Healthy Romanian Medical Students.
    Nastasa R; Stanciu C; Zenovia S; Singeap AM; Cojocariu C; Sfarti C; Girleanu I; Chiriac S; Cuciureanu T; Huiban L; Muzica CM; Trifan A
    Diagnostics (Basel); 2021 Dec; 11(12):. PubMed ID: 34943578
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Controlled Attenuation Parameter for Assessment of Hepatic Steatosis in Indian Patients.
    Rout G; Kedia S; Nayak B; Yadav R; Das P; Acharya SK; Gunjan D; Singh V; Mahanta M; Gupta S; Aggarwal S; Shalimar
    J Clin Exp Hepatol; 2019; 9(1):13-21. PubMed ID: 30765934
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A meta-analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver disease.
    Gu Q; Cen L; Lai J; Zhang Z; Pan J; Zhao F; Yu C; Li Y; Chen C; Chen W; Shen Z
    Eur J Clin Invest; 2021 Feb; 51(2):e13446. PubMed ID: 33128454
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Non-invasive diagnosis of liver steatosis using controlled attenuation parameter (CAP) and transient elastography.
    de Lédinghen V; Vergniol J; Foucher J; Merrouche W; le Bail B
    Liver Int; 2012 Jul; 32(6):911-8. PubMed ID: 22672642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative ultrasound, elastography, and machine learning for assessment of steatosis, inflammation, and fibrosis in chronic liver disease.
    Destrempes F; Gesnik M; Chayer B; Roy-Cardinal MH; Olivié D; Giard JM; Sebastiani G; Nguyen BN; Cloutier G; Tang A
    PLoS One; 2022; 17(1):e0262291. PubMed ID: 35085294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparing 2D-shear wave to transient elastography for the evaluation of liver fibrosis in nonalcoholic fatty liver disease.
    Karagiannakis DS; Markakis G; Lakiotaki D; Cholongitas E; Vlachogiannakos J; Papatheodoridis G
    Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):961-966. PubMed ID: 35913779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of Fibroscan, Shear Wave Elastography, and Shear Wave Dispersion Measurements in Evaluating Fibrosis and Necroinflammation in Patients Who Underwent Liver Biopsy.
    Seyrek S; Ayyildiz H; Bulakci M; Salmaslioglu A; Seyrek F; Gultekin B; Cavus B; Berker N; Buyuk M; Yuce S
    Ultrasound Q; 2024 Mar; 40(1):74-81. PubMed ID: 38345402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of Steatosis and Fibrosis using a new system implemented in an ultrasound machine.
    Sporea I; Bâldea V; Lupușoru R; Bende F; Mare R; Lazăr A; Popescu A; Șirli R
    Med Ultrason; 2020 Sep; 22(3):265-271. PubMed ID: 32399537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.